SCHEMBL27273679

SCHEMBL27273679

CC1CCCCCC(C)N(C(C)(C)C)C2CCCCCC12

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.32
PKM P14618 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22525803 0.78 GAA (0.36) GAAPKMTDP1
SCHEMBL21106299 0.78 GAA (0.36) GAAPKMTDP1
SCHEMBL24029420 0.78 GAA (0.36) GAAPKMTDP1
SCHEMBL18119019 0.75 ALDH1A1 (0.32) GAAPKMTDP1
SCHEMBL10205026 0.70 ACHE (0.39) TDP1
SCHEMBL3434003 0.70 ACHE (0.39) TDP1
SCHEMBL13245100 0.68
SCHEMBL17540070 0.67 ALDH1A1 (0.36) GAAPKMTDP1
SCHEMBL23613041 0.67 CYP2D6 (0.33) GAAPKMTDP1
SCHEMBL19336423 0.67 CYP1A2 (0.37) GAAPKMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024064080-A1 STAT6 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2024-03-28 WO disclosed